Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Hospital Universitário da Universidade de São Paulo
2018
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=576068169010 https://www.redalyc.org/journal/5760/576068169010/ https://www.redalyc.org/journal/5760/576068169010/html/ https://www.redalyc.org/journal/5760/576068169010/576068169010.epub https://www.redalyc.org/journal/5760/576068169010/movil |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis Joana Simões Isabel Augusto Sara Meireles Lurdes Vendeira Carlos Silva Medicina 223 Radium Dialysis Docetaxel Enzalutamide At a time when the population shows increasing longevity, entities such as cancer and chronic kidney disease (CKD) are more frequently connected. In the United States, approximately 6% of the patients on hemodialysis have cancer. The challenge to manage oncologic patients with CKD in a hemodialytic program represents a great shortage of available information on the choice of the best drug, timing, dosage adjustments, dialysis method, and treatment safety. We present the case of a patient with prostate cancer and terminal CKD in hemodialysis, and the treatment sequence after the development of resistance to hormonal blockade therapy, which included docetaxel, enzalutamide, and radium-223. 2018 artículo científico 2236-1960 https://www.redalyc.org/articulo.oa?id=576068169010 https://www.redalyc.org/journal/5760/576068169010/ https://www.redalyc.org/journal/5760/576068169010/html/ https://www.redalyc.org/journal/5760/576068169010/576068169010.epub https://www.redalyc.org/journal/5760/576068169010/movil 10.4322/acr.2018.011 en http://www.redalyc.org/revista.oa?id=5760 Autopsy and Case Reports application/pdf Hospital Universitário da Universidade de São Paulo Autopsy and Case Reports (Brasil) Num.2 Vol.8